FDA Cracks Down on Hims and Telehealth Drug Advertising
Federal health officials are now targeting telehealth companies that promote unofficial versions of prescription drugs, including popular weight loss medications. The FDA issued over 100 letters to various drugmakers and online prescribing companies, like Hims & Hers, warning them to remove “false and misleading” promotional statements from their websites. Specifically, the agency took issue with claims that compounded products contain “the same active ingredient” as FDA-approved drugs. Furthermore, the FDA also addressed misleading advertising from manufacturers of GLP-1 drugs, including an infomercial featuring Oprah Winfrey.
John Q. Hosedrinker